Patents by Inventor Stefanie Morgan

Stefanie Morgan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220282203
    Abstract: Disclosed herein are platforms, systems, and methods including a cell culture system that includes a cell culture container comprising a cell culture, the cell culture receiving input cells, a cell imaging subsystem configured to acquire images of the cell culture, a computing subsystem configured to perform a cell culture process on the cell culture according to the images acquired by the cell imaging subsystem, and a cell editing subsystem configured to edit the cell culture to produce output cell products according to the cell culture process.
    Type: Application
    Filed: March 7, 2022
    Publication date: September 8, 2022
    Inventors: Matthias WAGNER, Suvi AIVIO, Mariangela AMENDUNI, Catherine PILSMAKER, Arnaldo PEREIRA, Ananya ZUTSHI, Anthia TOURE, Steven NAGLE, Ozge WHITING, George HARB, Matthew SULLIVAN, Maya BERLIN-UDI, Stefanie MORGAN, Nick SEAY, Sang LEE, Scott LURO
  • Patent number: 11293018
    Abstract: Chromatin looping is key to gene regulation, yet no broadly applicable methods to selectively modify chromatin loops have been described. Disclosed herein is an engineered method for chromatin loop reorganization using CRISPR-dCas9 (CLOuD9) to selectively and reversibly establish chromatin loops. Disclosed herein is the power of this technology to selectively modulate gene expression at targeted loci.
    Type: Grant
    Filed: June 8, 2018
    Date of Patent: April 5, 2022
    Assignees: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY, SYSTEM BIOSCIENCES INC.
    Inventors: Kevin Chun-Kai Wang, Stefanie Morgan, Fangting Wu, Chiao-Chain Huang
  • Publication number: 20180355344
    Abstract: Chromatin looping is key to gene regulation, yet no broadly applicable methods to selectively modify chromatin loops have been described. Disclosed herein is an engineered method for chromatin loop reorganization using CRISPR-dCas9 (CLOuD9) to selectively and reversibly establish chromatin loops. Disclosed herein is the power of this technology to selectively modulate gene expression at targeted loci.
    Type: Application
    Filed: June 8, 2018
    Publication date: December 13, 2018
    Inventors: Kevin Chun-Kai Wang, Stefanie Morgan, Fangting Wu, Chiao-Chain Huang